D. Parker et al.
co-staining of the mitochondria. The emission spectrum of
the complex within the cells was recorded by using a home-
built, time-gated spectral-imaging microscope. The observed
spectra showed at least two DJ=0 components and were vir-
tually the same as those recorded in the cell-growth medium
at pH 7.6 and 6.0. The spectra most closely resembled a mix-
ture of the aqua complex and the serum albumin adduct.
Cell-growth medium contains a mixture of proteins (ca.
10 mgsmLÀ1) including serum albumin at a concentration of
about 5 mgmLÀ1 or 75 mm. Given that the association con-
stant measured for HSA with [Eu·L4]À was logKa =4.36, this
seems a reasonable assumption (Table 2 and Figure 6).
ring nitrogen or the p-aryl sites, the development of further
organelle-specific or responsive emissive probes may be ex-
pected, functioning at low concentration because of their
high inherent optical brightness.
Experimental Section
Details of instrumentation, ligand synthesis, methods of purification,
characterisation data and selected spectral titrations with added anions
and proteins are given in the Supporting Information.
Typical preparation of europiumACHTUNGTRNEUNG
(III) complex of L3: Synthesis of tert-bu-
toxycarbonyl-protected di-ethyl methylphosphinate ester of L3: Tert-butyl-
1,4,7-triazacyclononane-1-carboxylate (34 mg, 0.11 mmol) and ethyl(6-
(ethyl-methanesulfonate)-4-[2-(4-methoxyphenyl)ethynyl]pyridin-2-yl)-
AHCTUNGTREG(NNUN methyl)phosphinate, (96 mg, 0.23 mmol) were dissolved in CH3CN
(5 mL), and K2CO3 (53 mg, 0.39 mmol) was added. The mixture was stir-
red under argon at 658C and monitored by TLC (silica; CH2Cl2:5%
CH3OH, Rf (product)=0.48). After 12 h, the starting material had been
consumed and the reaction was cooled, the solution decanted from
excess potassium salts. The solvent was removed under reduced pressure,
and the crude material was purified by column chromatography (silica,
CH2Cl2/CH3OH 0–5% in 2% increments) to give a yellow oil (55 mg,
56%). 1H NMR (600 MHz, CDCl3) dH =7.96 (2H, m, H3), 7.65 (2H, bs,
3
3
H5), 7.44 (4H, d, JHÀH 8.5 Hz, H13), 6.87 (4H, d, JHÀH 8.5 Hz, H14), 4.11–
4.05 (2H, m, H7), 3.93, (2H, s, H1), 3.92 (2H, s, H1), 3.86–3.82 (2H, m,
H7), 3.81 (6H, s, H16), 3.35 (4H, br m, ring Hs), 3.08 (4H, br m, ring Hs),
2.68 (4H, br m, ring Hs), 1.75 (3H, d, JHÀP 15 Hz, H9), 1.74 (3H, d, JHÀP
2
2
Figure 6. Analytical reverse-phase HPLC trace of [Eu·L3
ACTHNUGTRNEUNG(H2O)]Cl. Major
isomer: tR =7.2 min; minor isomer: tR =8.5 min; [gradient: 10 to 100%
MeOH in water (0.05% formic acid) over 10 min].
15 Hz, H9), 1.46 (9H, s, H19), 1.23 (3H, t, JHÀH 7 Hz, H8), 1.22 ppm (3H,
3
t, JHÀH 7 Hz, H8); 13C NMR (151 Hz, CDCl3): d=161.6, 161.4 (d, JCÀP
3
3
20 Hz, C6), 160.5, 160.4 (s, C17), 155.6 (s, C15), 153.8, 153.6 (d, JCÀP
1
165 Hz, C2), 133.6, 133.5 (s, C15), 132.5 (br m, C4), 127.6 (br m, C3), 126.4,
126.1 (d, JCÀP 3 Hz, C5), 114.2, 114.1 (s, C14), 113.9, 113.8 (s, C12), 95.6,
4
95.3 (s, C11), 85.6, 85.4 (br m, C10),79.4 (s, C18) 62.8, 62.5 (s, C1), 60.9, 60.8
Conclusion
(d, JCÀP 3 Hz, C7), 55.3 (s, C16), 55.0–49.7 (br m, ring Cs), 28.6 (s, C19),
2
16.4 (d, JCÀP 6 Hz, C8), 13.3, 13.2 ppm (d, JCÀP 109 Hz, C9); 31P NMR
(243 MHz, CDCl3): dH =40.0, 39.9 ppm; HRMS (ESI): m/z calcd for
C47H60O8N5P2: 884.3917 [M+H]+; found 884.3937.
3
1
The europiumACHTUNGTRENNUNG(III) complexes of the five ligands examined
combine a high emission quantum yield in aqueous media
with two strongly absorbing arylkynyl–pyridyl chromo-
phores, generating “bright” complexes. Each complex pos-
sesses one coordinated water molecule in solution, except
for [Eu·L4]À, which shows evidence for self-association. The
water molecule can be displaced by a range of added anions
leading to emission intensity increases and a change in the
spectral fingerprint. In contrast to previously studied sys-
tems, simple carboxylates bind in a similar manner to a-hy-
droxy acids; proteins also seem to bind preferentially
through carboxylate ligation from Asp or Glu residues
(Scheme 2).
In solutions containing more than 10 mm bicarbonate, this
anion is bound selectively allowing its quantification in a
complex medium, such as human serum. The intensity ratio
of the emission bands centred at l=620 and 590 nm signals
the change in bicarbonate concentration for undiluted
serum samples, and it may be determined rapidly by using
time-gated emission spectroscopy, with excitation wave-
lengths in the range l=330–365 nm.
Synthesis of diethyl methylphosphinate ester of L3: The tert-butoxycarbon-
yl-protected diethyl methylphosphinate ester of L3 (65 mg, 0.074 mmol)
was dissolved in anhydrous CH2Cl2 (1 mL), and trifluoroacetic acid
(0.5 mL) was added. The solution was stirred under argon at 238C for
45 min. TLC analysis (silica; CH2Cl2:5% CH3OH), Rf (product)=0.12, Rf
(reactant)=0.52) was used to confirm that the protecting group removal
had gone to completion. The solvent was removed by using a high-
vacuum line (without heating), and the residue was re-dissolved in
CH2Cl2 (1 mL), which was again removed by using the same method.
This process was repeated five times to ensure complete removal of
excess trifluoroacetic acid. The crude material was purified by prepara-
tive HPLC to give the title product as a white solid (20 mg, 35%).
3
1H NMR (700 MHz, CDCl3): d=7.95 (2H, d, JHÀP 5.8 Hz, H3), 7.46 (4H,
3
3
d, JHÀH 8.9 Hz, H13), 7.41 (2H, bs, H5), 6.88 (4H, d, JHÀH 8.9 Hz, H14),
4.15–4.10 (2H, m, H7), 3.99 (4H, s, H1), 3.92–3.87 (2H, m, H7), 3.81 (6H,
s, H16), 3.19 (4H, br s, ring Hs), 3.07 (4H, br s, ring Hs), 2.69 (4H, br s,
ring Hs), 1.76 (6H, d, JHÀP 15.0 Hz, H9), 1.27 ppm (6H, t, JHÀH 7 Hz,
2
3
H8); 13C NMR (176 MHz, CDCl3): d=160.7 (s, C15), 159.3 (d, JCÀP 20 Hz,
3
C6), 154.4 (d, JCÀP 157 Hz, C2), 133.7 (s, C13), 133.1 (d, JCÀP 11 Hz, C4),
1
3
127.7 (d, JCÀP 20 Hz, C3), 126.3 (d, JCÀP 3 Hz, C5), 114.2 (s, C14), 113.5 (s,
2
4
C12), 96.4 (s, C11), 85.0 (s, C10), 61.1 (d, JCÀP 6.3 Hz, C7), 60.1 (s, C1), 55.3
2
(s, C16), 51.1–43.9 (br m, ring Cs), 16.5 (d, JCÀP 6 Hz, C8), 13.6 ppm (d,
3
1JCÀP 103 Hz, C9); 31P NMR (283 MHz, CDCl3): d=39.3; HRMS (ESI):
m/z calcd for C42H52O6N5P2 [M+H]+; found: 784.3387.
The more hydrophilic complexes studied herein, with
p-methoxy, p-oxyacetate or p-gluconamide substituents
readily enter mammalian cells, preferentially staining the
mitochondria at early time points, before migrating to the
lysosomes. Given the ease of attaching substituents to the
ACTHNUTRGNEUNG
Synthesis of [Eu·L3(H2O)]Cl: The diethyl methylphosphinate ester of L3
(15 mg, 20.6 mmol) was dissolved in CD3OD (3 mL), and NaOH (0.1m in
D2O, 1 mL) was added. The solution was stirred at 608C and monitored
by 1H NMR (loss of ethyl peaks) and 31P NMR spectroscopies (reactant
39.3 ppm, product 25.3 ppm) and stopped after 16 h. The pH of the solu-
9516
ꢀ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2013, 19, 9511 – 9517